Recommendations for Hepatitis B Immunoglobulin and Antiviral Prophylaxis Against Hepatitis B Recurrence After Liver Transplantation

dc.authoridHarputluoglu, Muhsin Murat Muhip/0000-0002-9415-147X
dc.authoridDanis, Nilay/0000-0002-3939-3089
dc.authoridKarasu, Zeki/0000-0002-4974-7944
dc.authoridakarsu, mesut/0000-0001-9217-948X
dc.authoridDAYANGAC, MURAT/0000-0002-1240-7233
dc.authoridADALI, GUPSE/0000-0003-2157-0304
dc.authoridOnem, Soner/0000-0001-9095-7567
dc.authorwosidHarputluoglu, Muhsin Murat Muhip/ABI-3094-2020
dc.authorwosidTuran, Ilker/A-7076-2017
dc.authorwosidDanis, Nilay/AFJ-8068-2022
dc.authorwosidKarasu, Zeki/W-1176-2018
dc.authorwosidAKYILDIZ, Murat/A-2760-2016
dc.authorwosidakarsu, mesut/AAV-9472-2021
dc.authorwosidSertesen, Elif/KJM-8461-2024
dc.contributor.authorAkarsu, Mesut
dc.contributor.authorOnem, Soner
dc.contributor.authorTuran, Ilker
dc.contributor.authorAdali, Gupse
dc.contributor.authorAkdogan, Meral
dc.contributor.authorAkyildiz, Murat
dc.contributor.authorAladag, Murat
dc.date.accessioned2024-08-04T20:10:09Z
dc.date.available2024-08-04T20:10:09Z
dc.date.issued2021
dc.departmentİnönü Üniversitesien_US
dc.description.abstractThe combination of hepatitis B immunoglobulin and potent nucleos(t)ide analogs after liver transplantation is considered as the standard of care for prophylaxis against hepatitis B virus recurrence. However, the recommended doses, route of administration, and duration of HBIG administration remain unclear. Moreover, hepatitis B immunoglobulin-free prophylaxis with potent nucleos(t)ide analogs has shown promising disease outcomes in preventing hepatitis B virus recurrence. The current recommendations, produced by the Turkish Association for the Study of the Liver, Acute Liver Failure and Liver Transplantation Special Interest Group, suggest a reduced need for hepatitis B immunoglobulin administration with effective long-term suppression of hepatitis B virus replication using potent nucleos(t)ide analogs after liver transplantation.en_US
dc.identifier.doi10.5152/tjg.2021.21608
dc.identifier.endpage719en_US
dc.identifier.issn2148-5607
dc.identifier.issue9en_US
dc.identifier.pmid34609299en_US
dc.identifier.scopus2-s2.0-85117952374en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage712en_US
dc.identifier.trdizinid512595en_US
dc.identifier.urihttps://doi.org/10.5152/tjg.2021.21608
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/512595
dc.identifier.urihttps://hdl.handle.net/11616/92613
dc.identifier.volume32en_US
dc.identifier.wosWOS:000703346600001en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherAvesen_US
dc.relation.ispartofTurkish Journal of Gastroenterologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectHepatitis Ben_US
dc.subjectliver transplantationen_US
dc.subjectrecurrenceen_US
dc.titleRecommendations for Hepatitis B Immunoglobulin and Antiviral Prophylaxis Against Hepatitis B Recurrence After Liver Transplantationen_US
dc.typeReview Articleen_US

Dosyalar